Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

47.82
Delayed Data
As of Feb 24
 +0.42 / +0.89%
Today’s Change
34.31
Today|||52-Week Range
67.74
+14.59%
Year-to-Date

Today’s Trading

Previous close47.40
Today’s open46.97
Day’s range45.84 - 48.67
Volume518,916
Average volume (3 months)776,065
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-60.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+18.22%
P/E ratioNM
Price/Sales23.36
Price/Book5.63

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-2.46-2.39%
PTLAPortola Pharmaceutic...+1.34+4.17%
PRTAProthena Corporation...-0.91-1.67%
CBMCambrex Corp+0.30+0.54%
Data as of 4:03pm ET, 02/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$69.9M
Annual profit (last year)-$198.5M
Net profit margin-283.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs